Avant Immunotherapeutics Inc. will see an additional $11.5 million in milestone payments for the rotavirus vaccine Rotarix, now that it has been FDA-approved. (BioWorld Today)

Medarex shares plummeted Wednesday as partner Pfizer Inc. unexpectedly halted a Phase III trial of potential melanoma treatment tremelimumab. (BioWorld Today)